Alzheimer disease

Medication to Treat Agitation for Alzheimer Disease Shows Mixed Results

Published February 24, 2014

Medication to Treat Agitation for Alzheimer Disease Shows Mixed Results
Anton P. Porsteinsson, M.D., of the University of Rochester School of Medicine and Dentistry, Rochester, N.Y., and colleagues randomized 186 patients with probable Alzheimer disease without major depression and clinically… Continue reading →

Proximal Humeral Reconstruction Using Nail Cement Spacer in Primary and Metastatic Tumours of Proximal Humerus.

Published August 10, 2013

Proximal humeral reconstruction using nail cement spacer in primary and metastatic tumours of proximal humerus.

Strategies Trauma Limb Reconstr. 2013 Aug 8;
Kundu ZS, Gogna P, Gupta V, Kamboj P, Singla R, Sangwan SS

Limb salvage surgery for malignant… Continue reading →

SLC1 Glutamate Transporters and Diseases: Psychiatric Diseases and Pathological Pain.

Published July 24, 2013

SLC1 Glutamate Transporters and Diseases: Psychiatric Diseases and Pathological Pain.

Curr Mol Pharmacol. 2013 Jul 22;
Nakagawa T, Kaneko S

The solute carrier family 1 (SLC1) consists of two neutral amino acid transporters and five high-affinity excitatory amino acid… Continue reading →

Don’t Be Too Strict With Yourself! Rigid Negative Self-Representation in Healthy Subjects Mimics the Neurocognitive Profile of Depression for Autobiographical Memory.

Published June 5, 2013

Don’t be Too Strict with Yourself! Rigid Negative Self-Representation in Healthy Subjects Mimics the Neurocognitive Profile of Depression for Autobiographical Memory.

Front Behav Neurosci. 2013; 7: 41
Sperduti M, Martinelli P, Kalenzaga S, Devauchelle AD, Lion S, Malherbe C,… Continue reading →

[Analysis of Clinical Pathway in Changing and Disabling Neurological Diseases.]

Published May 10, 2013

[Analysis of clinical pathway in changing and disabling neurological diseases.]

Rev Neurol (Paris). 2013 Apr 24;
Cordesse V, Jametal T, Guy C, Lefebvre S, Roussel M, Ruggeri J, Schimmel P, Holstein J, Meininger V

Neurological diseases are characterized by… Continue reading →

ED Management of Patients With Eating Disorders.

Published April 30, 2013

ED management of patients with eating disorders.

Am J Emerg Med. 2013 Apr 23;
Trent SA, Moreira ME, Colwell CB, Mehler PS

BACKGROUND: Eating disorders are one of the “great masqueraders” of the twenty-first century. Seemingly healthy young men… Continue reading →

[The Concept of Behavioral Addiction and Limits of the Term Addiction.]

Published April 23, 2013

[The concept of behavioral addiction and limits of the term addiction.]

Nervenarzt. 2013 Apr 21;
Mann K, Fauth-Bühler M, Seiferth N, Heinz A,

The numbers of persons with a prevalence for behavioral addiction are rising especially among the young.… Continue reading →

Late-Life Depression, Mild Cognitive Impairment, and Dementia.

Published April 20, 2013

Late-life depression, mild cognitive impairment, and dementia.

JAMA Neurol. 2013 Mar 1; 70(3): 374-82
Richard E, Reitz C, Honig LH, Schupf N, Tang MX, Manly JJ, Mayeux R, Devanand D, Luchsinger JA

To evaluate the association of late-life depression… Continue reading →

A New Fork in the Road: Lymphedema Bypass.

Published March 13, 2013

A New Fork in the Road: Lymphedema Bypass.

Adv Skin Wound Care. 2013 Mar 8;
Salcido RS

HubMed – rehab

The clinical spectrum of sport-related traumatic brain injury.

Nat Rev Neurol. 2013 Mar 12;
Jordan BD

Acute… Continue reading →

Depression Treatment: Organic Bases of Late-Life Depression: A Critical Update.

Published January 30, 2013

Organic bases of late-life depression: a critical update.

Filed under: Depression Treatment

J Neural Transm. 2013 Jan 25;
Jellinger KA

Late-life depression (LLD) is frequently associated with cognitive impairment and increases the risk of subsequent dementia. Cerebrovascular disease, deep… Continue reading →